Cellectar Biosciences, Inc. Convertible Preferred Stock, Shares Issued upon Conversion
Cellectar Biosciences, Inc. (CLRB) had Convertible Preferred Stock, Shares Issued upon Conversion of 2.79 million shares as of 2018-07-31, per its 10-K filed 2020-03-09.
Discontinued › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2020-03-09
- 2018-07-31: Convertible Preferred Stock, Shares Issued upon Conversion 2.79M shares.
- 2017-07-31: Convertible Preferred Stock, Shares Issued upon Conversion 2.79M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2018-07-31 | 2.79M shares 10-K · filed 2020-03-09 |
| 2017-07-31 | 2.79M shares 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |